leadf
logo-loader
ASX:CPH OTCQB:COPHF

Creso Pharma Ltd

Receive alerts
Market:
ASX
Market Cap:
$132.17 m
Price
0.11 AUD
Change
-4.35%
52 weeks high
0.47
52 weeks low
0.02

In brief

Creso Pharma Ltd (ASX:CPH) plans to bring the best of cannabis to better the lives of people and animals through its pharmaceutical expertise.

The company uses GMP (Good Manufacturing Practice) compliant development and manufacturing standards for its products as a reference for quality excellence with initial product registrations in Switzerland.

Creso Pharma also has worldwide rights for a number of unique and proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids.

Snapshot

Ahead of favourable regulatory changes in the US, the cannabinoid therapy developer hopes the dual listing will expedite growth and unlock value for existing Australian and new US shareholders.